Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Closed for Enrollment
-
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM IN RELIEVING, INTERRUPTING, AND PREVENTING CHRONIC MIGRAINE (RELIEV-CM2) (RELIEV-CM2)
Rochester, Minn.,
Jacksonville, Fla.,
Scottsdale/Phoenix, Ariz.
The purpose of this study is to evaluate the safety and efficacy of the ShiraTronics Migraine Therapy System.
-
CAT-Trial: CGRP monoclonal Antibody for Treatment of painful diabetic neuropathy:
a double-blind, randomized, placebo-controlled, international multicenter, phase II clinical trial (CAT-Trial)
Rochester, Minn.
The purpose of this study is to compare the change in pain intensity during treatment with a CGRP monoclonal antibody (eptinezumab) compared with placebo treatment in patients with painful diabetic polyneuropathy (DPN).
-
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Aneurysmal Subarachnoid Hemorrhage (BLOCK-SAH)
Jacksonville, Fla.
The purpose of this study is to assess the efficacy and safety of PPF-block to mitigate opiod use requirements and improve headache pain control in patients with aneurysmal SAH.
-
Quantitative Assessment of Painful Diabetic Peripheral Neuropathy after High Frequency Spinal Cord Stimulation: (QUANT) HF10 Study (QUANT)
Rochester, Minn.
The purpose of this study is to assess painful diabetic peripheral neuropathy after high-frequency spinal cord stimulation.
-
The Efficacy of Landmark-guided Percutaneous Sphenopalatine Ganglion Block on Self-reported Headache Pain Secondary to Aneurysmal Subarachnoid Hemorrhage: A Feasibility Study
Rochester, Minn.
The purpose of this study is to determine the feasibility of using SSPGB to reduce the self-reported headache pain that patients with aneurysmal SAH experience during their hospital admission.
.